Status:

UNKNOWN

Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of Rocuronium

Lead Sponsor:

Iuliu Hatieganu University of Medicine and Pharmacy

Conditions:

Incidence of Postoperative Residual Curarization

Eligibility:

All Genders

16-65 years

Phase:

EARLY_PHASE1

Brief Summary

Reversal of rocuronium-induced neuromuscular block by the combination of low-doses of neostigmine plus sugammadex decreases the cost of anesthetic medications, while maintaining efficacy of reversal i...

Detailed Description

Background Neuromuscular paralysis is a frequent requirement to facilitate airway management and surgery. Patients receiving neuromuscular blocking agents (NMBAs) are at risk of residual neuromuscular...

Eligibility Criteria

Inclusion

  • Patients scheduled for elective abdominal surgery
  • 16-65 years of age
  • BMI 30-39.9 ( obese class I-II)
  • American Society of Anesthesiologists (ASA) physical status II.
  • Surgery scheduled for general anesthesia and tracheal intubation and planned extubation at the end of surgery
  • Surgical procedures with an anticipated length of at least 60 min.

Exclusion

  • Emergency surgery
  • Patients unable to consent to study participation
  • Patients expected to be maintained on mechanical ventilation postoperatively
  • Contraindication to any of the study drugs
  • Patients with existing neuromuscular disease
  • Acute or chronic renal failure (GFR-EPI \<30 mL/min/1.73 m2)
  • Acute/chronic liver disease (Child-Pugh Score \>1)
  • Hyperkalemia (\> 5.3 mmol/l)
  • Pregnancy
  • History of stroke or ongoing paresis
  • Glaucoma
  • Breast feeding
  • Sepsis

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2018

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT03328312

Start Date

December 1 2017

End Date

June 1 2018

Last Update

November 1 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of Rocuronium | DecenTrialz